Upon antigen stimulation, naive T helper cells differentiate into distinct lineages to attain specialized properties and effector functions. T H 17 cells, a recently identified lineage of CD4 1 effector T cells, play a key role in the immune defense against fungi and extracellular bacteria, but also contribute to the pathogenesis of many autoimmune conditions. The differentiation of T H 17 cells is orchestrated by an intricate network of signaling pathways and transcriptional regulators in T cells. While the involvement of T cell-intrinsic pathways has been described extensively, we are just beginning to appreciate how T H 17 cell development is shaped by extrinsic pathways, especially the innate immune signals. Dendritic cells (DCs), the most important cell type to bridge innate and adaptive immunity, drive T H 17 cell differentiation by providing antigenic, costimulatory and cytokine signals. This is mediated by the recognition of innate and inflammatory signals by DCs via pattern recognition receptors, cytokine receptors and other immunomodulatory receptors that in turn activate the intracellular signaling network. In particular, p38a MAP kinase has emerged as a critical pathway to program DC-dependent T H 17 cell differentiation by integrating multiple instructive signals in DCs. Here, we summarize the current knowledge on the mechanisms by which DC-derived innate immune signals drive T H 17 cell differentiation.
INTRODUCTION
For more than 20 years, it has been appreciated that naive CD4
1 T cells can differentiate into distinct lineages to attain specialized properties and effector functions. For the initially identified T-cell subsets, T helper type 1 (T H 1) cells are characterized by high production of interferon-gamma (IFN-c) and are necessary to clear intracellular pathogens. T H 2 cells produce the signature cytokine interleukin-4 (IL-4) and are effective at controlling helminthes. 1 A new subset of IL-17-producing T (T H 17) cells has recently been described to mediate immune defense against fungi and extracellular bacteria and tissue inflammation in autoimmune diseases. T H 17 cell differentiation can be initiated by transforming growth factor-beta (TGF-b) in the presence of inflammatory cytokines IL-6 or IL-21, and is further reinforced by IL-23. T H 17 cells produce several signature cytokines including IL-17, IL-17F and IL-22, which provoke inflammatory responses including neutrophilia, tissue remodeling and production of antimicrobial proteins. [2] [3] [4] [5] In the absence of the proinflammatory inputs, TGF-b drives naive CD4
1 T cells to develop into induced Foxp3 1 regulatory T (iTreg) cells, which act in synergy with natural Treg (nTreg) cells to promote immune tolerance and inhibit autoimmunity. 5 Although the presence of additional T-cell subsets and the plasticity of T-cell lineage choices have been appreciated, these four T-cell populations represent the widely accepted major T-cell lineages ( Figure 1 ). The specification of T-cell lineages is orchestrated by an intricate network of signaling pathways and transcriptional master regulators in T cells. While the involvement of T cell-intrinsic pathways has been described extensively, how T-cell differentiation is triggered by extrinsic pathways and physiological stimuli is relatively less understood.
Antigen-presenting cells (APCs) drive T-cell differentiation by providing the antigenic, costimulatory and cytokine signals. Dendritic cells (DCs) are the most important APCs to bridge the crosstalk between innate and adaptive immunity. 6, 7 DCs express a repertoire of pattern recognition receptors (PRRs) that sense microbial pathogen products and endogenous ligands to initiate a signaling cascade culminating in the activation of DCs and induction of adaptive immunity. Activated DCs present high levels of major histocompatibility complex (MHC) molecules bearing pathogen-derived peptides, which engage T-cell receptors (TCRs) on naive antigen-specific T cells. This delivers the first activating signal to the T cell and is therefore referred to as 'signal 1'. DCs activated by pathogen encounter also upregulate costimulatory molecules to bind counter-receptors on T cells and transmit signals that are important for T-cell proliferation and survival (signal 2). Finally, activated DCs also produce cytokine and noncytokine mediators that act on the T cell to promote its differentiation into an effector cell (signal 3). The integration of these three classes of signals by the responding T cells, to a large extent, determines their subsequent fate. In this review, we summarize the recent findings on the mechanisms by which DC-mediated innate immune signals drive T H 17 cell differentiation and inflammation. We first provide a brief overview of intrinsic pathways, especially transcriptional mechanisms that specify the T H 17 lineage choice. We then discuss how DC-derived immune signals, especially the polarizing cytokines, mediate T H 17 cell differentiation by shaping the interface between DCs and T cells. We next describe how receptor-specific signals instruct DCs to drive T H 17 cell differentiation, by focusing on the roles of PRRs and other immunomodulatory receptors expressed by DCs. Finally, we highlight the emerging data that the stress-activated p38 MAP kinase (MAPK) pathway integrates diverse instructive signals in DCs for T H 17 cell differentiation.
INTRINSIC CONTROL OF T H 17 CELL DIFFERENTIATION: AN OVERVIEW
Since the seminal discovery of T H 17 cells as a separate lineage, 8, 9 multiple transcription factors have been identified as critical regulators of T H 17 cell differentiation. 10 Among the lineage-restricted transcription factors essential for T H 17 cell differentiation are two retinoic acid-related organ receptors, RORct and RORa. 11, 12 Similar to T-bet in T H 1 cells and GATA3 in T H 2 cells, RORct and RORa are highly induced in T H 17 cells and play central roles in specifying the lineage differentiation. Overexpression of either transcription factor promotes T H 17 cell differentiation when T H 1 and T H 2 differentiation is blocked. Deficiency of RORct, and to a considerably lesser extent, of RORa, impairs T H 17 cell differentiation, whereas loss of both factors completely inhibits T H 17 cell differentiation and suppresses the development of experimental autoimmune encephalitis (EAE), a T H 17-mediated autoimmune disease. 11, 12 Thus, RORct and RORa have redundant functions, with RORct playing a more dominant role in specifying the T H 17 cell fate.
Induction of RORct and RORa under T H 17-polarizing conditions is dependent upon STAT3, which perceives and transduces signals from IL-6, IL-23 and other cytokines. Deficiency of STAT3 decreases the expression of lineage-specific transcription factors and the T H 17 family cytokines, whereas enhancing STAT3 activity via deletion of the negative regulator SOCS3 increases IL-17 expression. [13] [14] [15] Aside from RORct, RORa and STAT3, additional transcriptional factors contribute to T H 17 cell differentiation and/or cytokine expression. These include IRF4, 16 BATF, 17 RUNX1, 18 and c-Maf, 19 most of which have additional roles in other aspects of T-cell lineage choices in the periphery or thymus. Finally, T H 17 cell differentiation is further shaped by transcription factors with prominent roles in environmental sensing. Two of the most notable examples are AHR and HIF1a, which sense environmental toxins and hypoxic conditions, respectively. [20] [21] [22] [23] Therefore, differentiation of T H 17 cells requires coordinated actions of multiple transcription factors. These transcriptional mechanisms act in synergy with the signaling networks, metabolic pathways and epigenetic regulators to perceive and transduce diverse lineage specification signals derived from DCs. 
IMMUNE SIGNALS AT THE DC/T CELL INTERFACE FOR T H 17 POLARIZATION

Antigenic signals
It has been known for some time that fate determination of T cells is shaped by the strength of TCR signals. Specifically, high antigen doses promote the generation of T H 1 cells, whereas low doses of the same antigen favor T H 2 cell polarization. 24, 25 The effects of antigen doses were later found to correlate with the extent of CD40L upregulation on T cells. 26 Iezzi et al. 27 recently reported that the strength of antigenic stimulation also critically influences T H 17 cell differentiation, because high, but not low or intermediate, antigen concentrations favor IL-17 production. Strong antigenic stimulation of T cells upregulates CD40L expression, which acts in concert with certain microbial stimuli to enhance IL-6 production from DCs to drive T H 17 polarization. Compared with T H 1 cells, T H 17 cells appear to require even stronger antigen stimulation for their development, and this is associated with profound upregulation of CD40L expression on T cells that in turn delivers CD40L-CD40-mediated costimulation to DCs. 27 Indeed, CD40 deficiency diminishes IL-6 production from DCs and markedly reduces T H 17 responses in models of EAE and stimulation with the Gram-positive bacterium Propionibacterium acnes. 27, 28 We also observed defective T H 17 cell differentiation mediated by CD40-deficient DCs in vitro, suggesting the involvement of direct DC and T-cell interaction. 29 Therefore, high antigen concentrations favor T H 17 cell differentiation by fostering the CD40L-CD40 crosstalk at the DC/T cell interface.
Costimulatory molecules
DCs express a number of costimulatory molecules including CD80 (B7-1) and CD86 (B7-2) on their cell surface to engage the corresponding receptors, such as CD28, on T cells. This interaction transmits signals to promote T-cell proliferation and survival. Park et al. 8 reported that APCs deficient in both B7 molecules failed to instruct Tcell differentiation into T H 17 cells. Odobasic et al. 30 later demonstrated that inhibition of CD86, but not CD80, suppressed IL-17 production from splenocytes and decreased T-cell accumulation in the joints in the model of antigen-induced arthritis. Consistent with this, our recent study indicated that blocking CD86 function downregulated DC-dependent T H 17 cell differentiation in vitro. 29 Conversely, CTLA-4, a negative factor for T-cell activation that also interacts with B7 molecules on DCs, inhibits T H 17 cell differentiation in vitro and in vivo and suppresses T H 17-mediated autoimmunity. 31 The inducible costimulatory ICOS is another member of the CD28 superfamily that also regulates naive T-cell activation. ICOS signaling in T cells is required for efficient T H 17 development and expansion in both murine and human systems, 8, 32 indicating the therapeutic potentials of ICOS modulation for the treatments of T H 17-dependent disorders. ICOS functions by inducing c-Maf and transactivating IL-21, an important T-cell autocrine factor for T H 17 cell differentiation. 19 These findings collectively indicate that T H 17 cell differentiation requires selective costimulatory signals from DCs.
Polarizing cytokines
Among the most potent factors to polarize T H 17 cell differentiation are STAT3-activating cytokines IL-6, IL-21 and IL-23, along with TGF-b and IL-1. IL-6, IL-23 and IL-1 are mainly produced by the innate immune system especially DCs, whereas IL-21 and TGF-b can be produced by T cells in an autocrine/paracrine manner to further shape T H 17 cell development. Earlier studies showed that IL-17-producing cells could be efficiently generated in vitro from naive CD4
1 T cells activated with TCR and costimulation in the presence of IL-6 and TGF-b. [33] [34] [35] Although less effective than IL-6 in initiating T H 17 cell differentiation, IL-21 produced by developing T H 17 cells has an important role to propagate the differentiation process. 15, 36, 37 In contrast to IL-6, IL-23 does not act on naive T cells, because the receptor for IL-23 is induced only in T cells after stimulation in the presence of IL-6 or IL-21. Therefore, IL-23 is more important in the later phase of T H 17 cell differentiation and in the maintenance of the T H 17 phenotype. 38 However, this function of IL-23 is indispensable for the pathogenicity of T H 17 cells, as mice lacking IL-23 are completely resistant to EAE. 39 The roles of IL-23 signaling in the development of human T H 17-related autoimmune diseases were further highlighted by recent findings showing the association of IL-23R polymorphisms and the prevalence of several autoimmune diseases. 40 Therefore, the three STAT3-activating cytokines, IL-6, IL-21 and IL-23, are critically involved in the initiation, amplification and stabilization stages of T H 17 cell differentiation, respectively. Another proinflammatory cytokine, IL-1, also pays a crucial role in early T H 17 cell differentiation by signaling through IL-1R1 and the downstream Myd88-TRAF6 pathway to promote IRF4 and RORct expression in T cells. 41, 42 Compared with the well-described roles of these proinflammatory cytokines in T H 17 responses, whether and how the immunosuppressive cytokine TGF-b regulates T H 17 cell differentiation remain incompletely understood. Addition of TGF-b to IL-6 or IL-21 enhances the development of T H 17 cells in vitro, 15, 36, 37 and deletion of TGF-b1 specifically from T cells lowers T H 17 cell generation and EAE. 43 Moreover, phagocytosis of infected apoptotic cells by DCs triggers the release of both IL-6 and TGF-b to instruct T H 17 cell differentiation during infection. 44 However, high doses of TGF-b downregulate the expression of IL-23R, the key pathogenic molecule associated with T H 17 cells, and instead provoke Foxp3 expression and iTreg induction. 45 Further, Ghoreschi et al. 47 Moreover, DCs were also shown to be an important source of TGF-b for T H 17 cell differentiation. 48 Consistently with this notion, expression of the integrin avb8, which is required to activate TGF-b, plays a critical role in the differentiation of T H 17 cells. 49, 50 Additional studies are required to ascertain the precise function and regulation of TGF-b in T H 17 cell differentiation.
T H 17 cell differentiation is shaped by both positive and negative polarizing cytokines. IL-27 is arguably the most potent cytokine produced by DCs to limit T H 17 cell differentiation and autoimmune inflammation. Mice deficient in IL-27R are hyper-susceptible to EAE and other inflammatory disorders and generate more T H 17 cells. [51] [52] [53] Multiple mechanisms mediate the effects of IL-27 for the inhibition of T H 17 cell development. 54 A particularly important mechanism is IL-27-dependent induction of IL-10-expressing Tr1 cells that play a central role in downregulating the proinflammatory T H 17 cell responses. [55] [56] [57] Furthermore, IL-27 inhibits T H 17 cell differentiation via directly inhibiting RORct and RORa expression and promoting T-bet expression and T H 1 generation. 54 In addition to IL-27, production of IL-10 by DCs has also been shown to inhibit T H 17 cell differentiation via constraint of IL-1 production by DCs. 58 Several T cell-derived cytokines, such as IFN-c, IL-4 and IL-2, have also been shown to inhibit T H 17 cell development. 8, 9, 59, 60 Since DCs are not the major producer of these cytokines, such regulation is not further discussed here. The readers are encouraged to read excellent reviews on this topic. [2] [3] [4] [5] In summary, differentiation of T H 17 cells is largely determined by the innate immune signals transduced from DCs and the integration of these signals by responding T cells. In particular, DC-derived cytokines deliver a critical 'signal 3' to T cells, to mediate both positive and negative regulation of T H 17 cell differentiation. Aside from antigens, costimulation and cytokines, recent work has identified that differentiation of T H 17 cells is influenced by additional immune modulators produced by DCs. For example, retinoic acid, a vitamin A metabolite produced by CD103
1 DCs in the gut-associated lymphoid tissues, inhibits T H 17 cell differentiation while promoting iTreg generation by activating the retinoic acid receptor. [61] [62] [63] Moreover, while the crosstalk between DC and T cells plays a central role in programming T H 17 cell differentiation, additional cell types modulate functions of DCs and T cells and/or the immune microenvironment to impinge upon T H 17 cell differentiation. In this context, mice deficient for cd T cells have markedly attenuated T H 17-mediated autoimmune disease. 64 Mechanistically, IL-17 expressed by this lymphocyte subset activates IL-17R on epithelial and stromal cells, resulting in the production of IL-6, IL-1 and other inflammatory cytokines that act in a positive feedback loop on the cd T cells and differentiating T H 17 cells to amplify inflammation. 65 directly compared the effects of different pathogens to elicit T H 17 responses, and found that the fungus Candida albicans was much more potent than various bacteria tested to induce IL-17 production from human peripheral blood mononuclear cells. We also found that heat-killed fungi had much greater adjuvant activity than bacteria to stimulate antigen-specific T cells to differentiate into T H 17 effector cells in vivo. 29 Further, under steady-state conditions, a sizable population of IL-17 1 CD4 1 T cells is detectable in gut-associated lymphoid tissues such as lamina propia from small intestine in response to commensal microbiota. 66 How do the diverse innate stimuli and microbial agents instruct T H 17 responses? PRRs expressed by DCs, including Toll-like receptors (TLRs), C-type lectin receptors (CLRs) and NOD-like receptors (NLRs), are essential to sense these T H 17-instructive stimuli. Cytokine receptors and other immunomodulatory receptors also contribute to DC-mediated T H 17 cell differentiation (Figure 2) . Here, we summarize the functions of these receptors, including mechanisms by which these receptors transduce signals via receptor-proximal downstream signaling.
TLRs
TLRs, the first group of PRRs identified, are classically considered to polarize toward T H 1 responses. 67 Recent studies indicate that ligation of certain TLRs on DCs potentiates T H 17 cell differentiation by affecting production of T H 17-polarizing cytokines.
27,68,69 TLRmediated effects on T H 17 responses are generally much weaker than those induced by CLRs (see below for details). 70, 71 Further, several TLRs, including TLR2, TLR6 and TLR7, have been implicated in negatively regulating T H 17 responses in inflammatory and infectious models. [72] [73] [74] [75] This is associated with the abilities of these receptors to downregulate IL-23 production from DCs. Therefore, TLR signaling in DCs can either positively or negatively regulate T H 17 cell differentiation, in a receptor and stimulation-specific manner. It should also be noted that T cells themselves express TLRs and respond to TLR stimulation. T cells stimulated with TLR2 agonists exhibit enhanced T H 17 cell differentiation, and loss of TLR2 in CD4 1 T cells ameliorates EAE. 76 The cell type-specific roles of TLRs in T H 17 cell differentiation require additional studies, which can be assisted with the generation and analysis of conditional alleles of these receptors.
CLRs
CLRs are a large family of proteins characterized by the presence of one or more C-type lectin-like domains. Several CLRs recognize carbohydrates in the cell wall of fungi and other pathogens (such as b-glucans) and signal through the intracellular kinase Syk to initiate inflammatory responses in both innate and adaptive immunity. 77 Ligation of these CLRs on DCs is an important mechanism by which fungal infection induces strong T H 17 cell responses. LeibundGut-Landmann et al. 70 reported that the prototypical CLR, Dectin-1 (also known as CLEC7a), activates Syk and the adaptor CARD9 to promote DC maturation and production of T H 17-polarizing cytokines, thereby instructing T-cell differentiation into the T H 17 lineage. Infection with C. albicans induces CARD9-dependent T H 17 responses and protective immunity. Further studies showed that Dectin-2 (CleC6A), which also signals through Syk and CARD9, is even more potent than Dectin-1 to mediate T H 17 cell responses and protection from C. albicans infection. 78, 79 Moreover, mannose receptor, another member of the CLR family, is also important to induce IL-17 production in response to C. albicans. 65 These results collectively highlight potent effects of CLRs in driving T H 17 responses. Moreover, synergic interactions between CLRs and TLRs further modulate T-cell fate. 79, 80 NLRs NLRs are a family of innate immune receptors for intracellular microbial sensing characterized by the presence of a conserved NOD domain. 81 NLRs are implicated in a multitude of innate immune signaling pathways ranging from the regulation of MAPK and NFkB signaling pathways by NOD1 and NOD2, to the assembly of caspase-1-activating protein complexes named 'inflammasomes' by 82 Moreover, mice deficient in NOD1, NOD2 or RIP2 are resistant to EAE, associated with diminished activation of central nervous system (CNS)-infiltrating DCs and IL-17 expression from CNS T cells. 83 Aside from the NOD proteins, NLRP3-mediated inflammasome complex, which activates caspase-1 to process pro-IL-1b and pro-IL-18, has been shown to regulate T H 17 cell generation. Deficiency of NLRP3, the downstream adaptor ASC, or caspase-1 ameliorates EAE pathogenesis. Mechanistically, this is linked to the requirement of NLRP3 to promote IL-1 and IL-18 production from DCs for the potentiation of T H 17 responses. [84] [85] [86] The role of NLRP3 to mediate DCdependent T H 17 cell responses has also been observed in infection models of Bordetella pertussis and C. albicans. 87, 88 Conversely, hyperactivation of NLRP3 causes excessive IL-1b production from APCs, leading to augmented T H 17 cell differentiation and T H 17 cell-dominant immunopathology. 89 Therefore, activation of NLPR3-mediated inflammasome by DCs promotes T H 17 cell differentiation via IL-1b and/or IL-18 in autoimmune, infectious and inflammatory models.
Cytokine receptors
In addition to recognizing microbial products through PRRs, DCs sense signals transduced from cytokines. The proinflammatory cytokine TNF-a promotes DC production of IL-23, whereas blocking TNF-a activity suppresses T H 17 responses and inflammation in psoriasis patients. 90 The receptor for stem cell factor, c-Kit (a receptor tyrosine kinase), is upregulated on DCs by T H 17-and T H 2-skewing stimuli such as allergens and allergy-inducing adjuvants, but not by T H 1-inducing adjuvants. 91 Upregulation of c-Kit on DCs results in PI3K activation and elevated IL-6 secretion that in turn promotes T H 17 and T H 2 cell differentiation. DCs expressing nonfunctional cKit are unable to induce robust T H 17 and T H 2 responses and airway inflammation, highlighting the importance of the c-Kit/PI3K/IL-6 signaling axis in DCs in instructing T H 17 responses. 91 Conversely, IFN-b, an effective therapy against relapsing-remitting multiple sclerosis, has recently been shown to suppress T H 17 cell differentiation by altering the production of T H 17-polarizing cytokines from DCs. [92] [93] [94] Engagement of type I IFN receptor (IFNAR) by IFN-b on DCs prevents the expression of an intracellular isoform of osteopontin, termed iOpn, an inhibitor of IL-27. Mice containing DC deficient in iOpn produce excessive amounts of IL-27 and develop a delayed EAE disease associated with diminished IL-17 responses. These studies identify an IFNAR/iOpn axis that restrains T H 17 cell development. 93 However, it should be noted that IFN-b is ineffective and might worsen clinical status in multiple sclerosis and other diseases when a T H 17 immune response is prominent. 95, 96 This probably reflects the effects of IFN-b on cells other than DCs, and highlights the complex roles of IFNAR in the pathogenesis and treatment of autoimmune diseases. Interestingly, ligation of IFN-c receptor (IFNGR) expressed by DCs leads to suppression of IL-17 production while inducing IL-10 from T cells, and this is mediated by the ability of IFN-c to induce the expression of IL-27 but inhibit that of the secreted form of osteopontin. 97, 98 Cytokine receptor signaling in DCs therefore shapes differentiation of T H 17 cells.
Receptors for additional immune modulators
DCs employ additional receptors to link inflammatory and environmental cues to proper T-cell lineage decision. Ligation of CD40 on DCs by T cell-expressed CD40L endows DCs with the ability to promote T H 17 cell differentiation via IL-6. 27, 28 Stimulation of the chemokine receptor CCR7 by its ligands promotes the expression of IL-23 from DCs and IL-23-dependent generation of pathogenic T H 17 cells in EAE. 99 Adenosine is an endogenous metabolite produced during hypoxia or inflammation. Recent studies indicate that adenosine acts via A 2B adenosine receptor on DCs to promote IL-6 expression and development of T H 17 cells.
100 PGE 2 , a major lipid mediator released in inflammatory conditions, induces IL-17 production in activated T cells in the model of inflammatory bowel disease. PGE 2 signals through the EP2/EP4 receptors on DCs to shift the IL-12/IL-23 balance in DCs in favor of IL-23. 101 Analysis of mice deficient in EP2 or EP4 reveals that PGE 2 facilitates T H 17 cell generation in EAE redundantly through these two receptors. 102 As described above, AHR acts in a T cell-intrinsic manner to modulate T H 17 cell differentiation. 20, 21 Interestingly, AHR was recently shown to negatively regulate DC immunogenicity by inducing expression of IL-10 and indoleamine 2,3-dioxygenase, an immunosuppressive enzyme. 103 Absence of AHR in DCs inhibits iTreg development and facilitates T H 17 cell generation from naive T cells, 103 whereas DCs activated with AHR suppresses EAE upon transfer. 104 Another DC pathway negatively regulating T H 17 cell responses is mediated by the Wnt-Frizzled (fzd) receptor and the downstream b-catenin signaling. Manicassamy et al. 105 reported that DC-specific deletion of b-catenin disrupts intestinal homeostasis and results in lower frequency of Treg cells but increased percentages of effector T H 17 and T H 1 cells. Deficiency of b-catenin in DCs alters the balance of proinflammatory and anti-inflammatory cytokines and exacerbates the inflammatory response in an inflammatory bowel disease model, highlighting that b-catenin signaling in DCs promotes intestinal homeostasis and tolerance. 105 Therefore, diverse receptors in DCs translate inflammatory mediators and environmental cues into proper T H 17 cell generation.
In summary, DCs sense pathogenic agents, immune stimuli and environmental cues through a plethora of receptors. In each case, the ligand and receptor interaction initiates a specific signaling cascade in DCs culminating in the expression of T H 17-polarizing cytokines and other factors, which then positively or negatively modulate T H 17 cell differentiation. In general, activation of DC receptors induces simultaneous development of multiple T-cell subsets, not just T H 17 cells alone. Given the well-described cross-regulation between T-cell subsets, [3] [4] [5] whether T H 17 cell differentiation is directly or specifically shaped by the signals transduced from DC receptors requires additional studies in many contexts. Moreover, it remains poorly understood how the kaleidoscopes of innate signals are integrated to shape T-cell fate decision. Although different mechanisms are likely to exist, we have recently identified that p38a MAPK signaling serves as an important converging point in DCs to integrate these diverse signals to mediate T H 17 responses, which is further discussed below. and inflammatory diseases, and inhibitors of these pathways have been evaluated as new therapeutics for these disorders. 107 As a matter of fact, among all of the protein kinase targets for the development of anti-inflammatory drugs in the pharmaceutical industry, p38a MAPK is by far the most extensively investigated protein, but severe side effects have prevented clinical advancement of many p38a inhibitors. 107 In DCs, p38a is expressed at much higher levels than the other three p38 isoforms (p38b, c and d). Importantly, p38 activation is greatly elevated in DCs treated with various types of T H 17-instructive signals (including engagements of Dectin-1 and CD40 receptors and stimulation with heat-killed C. albicans), relative to T H 1-polarizing stimuli. These findings suggest a potential role for p38a to mediate DC-dependent T H 17 cell differentiation by integrating T H 17-instructive signals (Figure 3) . 29 To dissect the selective role of p38a in DCs, we generated mice with DC-specific deletion of p38a and established a central role for p38a to program DC-dependent T H 17 cell differentiation and autoimmune CNS inflammation.
29 p38a in DCs mediates reciprocal regulation of IL-6 and IL-27, arguably the most potent positive and negative regulators of T H 17 polarization, respectively, and further imprints STAT3 signaling and IL-23R expression in responding T cells. Additionally, p38a is important for optimal CD86 expression on DCs and shapes strength of the costimulatory signals, thereby orchestrating a program for DC-dependent T H 17 cell differentiation. Moreover, p38a is required for tissue-infiltrating DCs to sustain T H 17-dependent neuroinflammation, and also contributes to T H 17 cell generation in response to commensal microbiota and fungal infection. Mechanistically, p38a integrates diverse T H 17-instructive signals (TLRs, CLRs and CD40) in DCs and further links them to a core set of downstream signaling and transcriptional regulators for the expression of DC-derived 'signals 2 and 3'. These findings identify p38a signaling as a central pathway for the integration of instructive signals in DCs for T H 17 cell differentiation and inflammation. 29 Negative regulation of MAPK activity is effected primarily by MKPs, a group of over 10 dual-specificity phosphatases that dephosphorylate the MAPK on their regulatory threonine and tyrosine residues. MKP-1 (DUSP1), the protypical member of this family, is a key negative regulator of innate immune responses by limiting the activation of MAPKs. 108 DCs lacking MKP-1 exhibit higher activity of p38, and to a lesser extent, JNK. 71 These mutant DCs show increased ability to drive T H 17 cell differentiation but are defective to mediate T H 1 cell differentiation, suggesting that MKP-1 signaling in DCs programs reciprocal T H 1 and T H 17 cell differentiation. This is mediated by the effects of MKP-1 to modulate the IL-12/STAT4 and IL-6/STAT3 axes at the DC/T cell interface, and T-cell expression of IL-12Rb2 and IL-23R (which pair with IL-12Rb1 to constitute functional IL-12 and IL-23 receptors, respectively). Deficiency of MKP-1 in innate immune cells disrupts in vivo immune responses against infections and immunization and promotes T cell-mediated inflammation. Moreover, MKP-1 inhibits induction of iTreg cells by downregulating TGF-b2 production from DCs. Our findings identify a regulatory circuit linking MKP-1 signaling in DCs, production of immunomodulatory cytokines, and integration of DC-derived signals via STAT activation and cytokine receptor expression in T cells, that bridges innate and adaptive immunity and coordinates protective immunity and immunopathology. 71 Notably, whereas MKP-1 and p38a in DCs have reciprocal effects on T H 17 cell differentiation, deficiency of MKP-1 also impairs T H 1 cell generation, but p38a does not play a crucial role in this process. 29, 71 These results highlight the complex interactions between MKP-1 and p38a. For example, MKP-1 inhibits JNK, as well as p38, but also depends upon p38 for its transcriptional induction. 109, 110 Altogether, our studies identify the MKP-1/p38a axis as a key mechanism of DCmediated programming of T H 17 cell differentiation (Figure 3) , and lend strong rationale for therapeutic modulation of this pathway in DCs as a potential treatment for autoimmune conditions mediated by T H 17 cells. 29, 71 CONCLUSIONS Dependence of T cell-mediated adaptive immunity on innate immune signals and DCs has been known for a long time, 111 and the identification of TLRs and other PRRs has revolutionized our understanding of immune responses. 6 More recent studies have demonstrated that engagements of PRRs and other receptors endow DCs with the ability to shape the differentiation of T H 17 cells, one of the most proinflammatory cell types. While recognition of innate and inflammatory stimuli begins at the receptor level, it is the signaling components downstream of each receptor and the way they interact with each other that ultimately determines the specific immunological outcome. The 113 has yet to be determined. As for the molecular pathways in DCs, the development of CD11c-Cre mice for DC-specific gene targeting has been instrumental to our understanding of DC-mediated innate and adaptive immunity. 114 We anticipate the extensive use of this approach to address DC pathways for in vivo T H 17 responses in the near future. However, given the heterogeneity of DC populations, the CD11c-Cre system does not allow the analysis of all DC subsets in vivo. More sophisticated strategies to target DCs are required to fully appreciate how DC-mediated innate signals mediate adaptive immunity and T H 17 cell differentiation. Addressing this issue is not only insightful to understanding fundamental mechanisms of immune regulation, but is also relevant to the investigations of disease mechanisms and therapeutic interventions of a number of autoimmune and inflammatory disorders.
